Serotonin and depression: pathophysiological mechanism or marketing myth?
- 1 September 2008
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 29 (9) , 433-436
- https://doi.org/10.1016/j.tips.2008.05.004
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug AdministrationPLoS Medicine, 2008
- 5-HTT Binding in Recovered Depressed Patients and Healthy Volunteers: A Positron Emission Tomography Study With [ 11 C]DASBAmerican Journal of Psychiatry, 2007
- Serotonin-1A receptor imaging in recurrent depression: replication and literature reviewNuclear Medicine and Biology, 2007
- Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studiesMolecular Psychiatry, 2007
- Consensus paper of the WFSBP Task Force on Biological Markers: Biological Markers in DepressionThe World Journal of Biological Psychiatry, 2007
- The endophenotype concept in psychiatric geneticsPsychological Medicine, 2006
- Serotonin and Depression: A Disconnect between the Advertisements and the Scientific LiteraturePLoS Medicine, 2005
- Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635Molecular Psychiatry, 2004
- Reduced Serotonin Type 1AReceptor Binding in Panic Disorder: Figure 1.Journal of Neuroscience, 2004
- Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT GeneScience, 2003